Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
![PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a63c762e0fa3c8d5b24bb90bbf75a3ae3fff0174/6-Figure1-1.png "PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar")
PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar
Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease
Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis - ScienceDirect
Frontiers | Review: The Role of Intestinal Dysbiosis in Parkinson's Disease
Frontiers | What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?
PDF) Lipopolysaccharide Animal Models for Parkinson's Disease
Inflammatory Animal Models of Parkinson's Disease - IOS Press
The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson's Disease
Frontiers | Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
Frontiers | The Gut–Brain Axis and Its Relation to Parkinson's Disease: A Review
Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation - ScienceDirect
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
IJMS | Free Full-Text | Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats
Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway | Scientific Reports
DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice
Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson's Disease | ACS Chemical Neuroscience
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Barbigerone Potentially Alleviates Rotenone-Activated Parkinson's Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines | ACS Omega
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins | PLOS ONE
Microbes and Parkinson's disease: from associations to mechanisms: Trends in Microbiology
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease | Semantic Scholar
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
Lipopolysaccharide Animal Models for Parkinson's Disease
